SeaStar Medical Holding (ICU) Change in Receivables (2024 - 2026)
SeaStar Medical Holding's (ICU) quarterly Change in Receivables came in at -$58000.0 in Q1 2026, down 2800.0% YoY from $2148.1 in Q1 2025, and down 462.5% on a QoQ basis from $16000.0 in Q4 2025.
SeaStar Medical Holding (ICU) Change in Receivables (2024 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 3 years of Change in Receivables data on file, last reported at -$58000.0 in Q1 2026.
- Quarterly Change in Receivables fell 2800.0% year-over-year to -$58000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69000.0 (down 37.27% YoY) and the FY2025 annual result came in at $125000.0, up 11.61% from the prior year.
- Change in Receivables retreated to -$58000.0 in Q1 2026, from $16000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $107000.0 in Q2 2025 to a low of -$58000.0 in Q1 2026.
- A 3-year average of $25571.4 and a median of $16000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2025 — Change in Receivables tumbled 63.64% — and 2026, when it plunged 2800.0%.
- Tracing ICU's Change in Receivables over 3 years: stood at $44000.0 in 2024, then plunged by 63.64% to $16000.0 in 2025, then plunged by 462.5% to -$58000.0 in 2026.
- The last three Change in Receivables figures came in at -$58000.0 (Q1 2026), $16000.0 (Q4 2025), and $4000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 29,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29,000.00 |
| Jun 30, 2026 | 29,000.00 |
| Mar 31, 2026 | -58,000.00 |
| Mar 31, 2026 | -58,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 107,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |